News
World AIDS Day: Are long-acting HIV therapies the future?
01 December 2021
AGILE COVID-19 drug testing platform opens new trial in South Africa
07 October 2021
Tandem Nano secures licence agreement for long-acting technologies for malaria, tuberculosis, and hepatitis C
21 September 2021
New Unilever Radiochemistry Research Fellow
25 May 2021
The Nanotherapeutics Hub joins iiCON
18 May 2021
Long-acting injectable medicine as potential route to COVID-19 therapy
14 April 2021
Two new therapies to be tested in ground-breaking COVID-19 clinical trial
12 January 2021
Liverpool launches new Centre of Excellence for Long-acting Therapeutics
12 January 2021
Study highlights risks associated with the sequential infection of influenza followed by COVID-19
15 October 2020
Exchanging knowledge at the edge of pharmacology and materials chemistry
24 March 2022
World AIDS Day: Are long-acting HIV therapies the future?
01 December 2021
AGILE COVID-19 drug testing platform opens new trial in South Africa
07 October 2021
Tandem Nano secures licence agreement for long-acting technologies for malaria, tuberculosis, and hepatitis C
21 September 2021
New Unilever Radiochemistry Research Fellow
25 May 2021
The Nanotherapeutics Hub joins iiCON
18 May 2021